speb/financial-data huggingface dataset:
MLAB income_statement (quarterly, 2024-12-31) — +Total Revenue: 62840000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 4087000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 38647000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -26036000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -1060000.00
MLAB cash_flow (quarterly, 2024-12-31) — Amortization Cash Flow: 4391000.00
MLAB cash_flow (quarterly, 2024-12-31) — Amortization Of Intangibles: 4391000.00
MLAB income_statement (quarterly, 2024-12-31) — Basic Average Shares: 5429000.00
MLAB income_statement (quarterly, 2024-12-31) — Basic EPS: -0.31
MLAB cash_flow (quarterly, 2024-12-31) — Beginning Cash Position: 24337000.00
MLAB cash_flow (quarterly, 2024-12-31) — Capital Expenditure: -813000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 15896000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Capital Stock: 352788000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 30956000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 30956000.00
MLAB cash_flow (quarterly, 2024-12-31) — Cash Dividends Paid: -869000.00
MLAB cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Financing Activities: -10287000.00
MLAB cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Investing Activities: -813000.00
MLAB cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Operating Activities: 18129000.00
MLAB cash_flow (quarterly, 2024-12-31) — Change In Account Payable: -1730000.00
MLAB cash_flow (quarterly, 2024-12-31) — Change In Accrued Expense: 3815000.00
MLAB cash_flow (quarterly, 2024-12-31) — Change In Inventory: -495000.00
MLAB cash_flow (quarterly, 2024-12-31) — Change In Other Working Capital: 460000.00
MLAB cash_flow (quarterly, 2024-12-31) — Change In Payable: -1730000.00
MLAB cash_flow (quarterly, 2024-12-31) — Change In Payables And Accrued Expense: 2085000.00
MLAB cash_flow (quarterly, 2024-12-31) — Change In Prepaid Assets: 856000.00
MLAB cash_flow (quarterly, 2024-12-31) — Change In Receivables: 657000.00
MLAB cash_flow (quarterly, 2024-12-31) — Change In Working Capital: 3563000.00
MLAB cash_flow (quarterly, 2024-12-31) — Changes In Account Receivables: 657000.00
MLAB cash_flow (quarterly, 2024-12-31) — Changes In Cash: 7029000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Common Stock: 352788000.00
MLAB cash_flow (quarterly, 2024-12-31) — Common Stock Dividend Paid: -869000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 155214000.00
MLAB income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 23086000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Current Accrued Expenses: 11947000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Current Assets: 110845000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 3535000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Current Debt: 100913000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 104448000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Current Deferred Liabilities: 14608000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Current Deferred Revenue: 14608000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 155878000.00
MLAB cash_flow (quarterly, 2024-12-31) — Depreciation: 1106000.00
MLAB cash_flow (quarterly, 2024-12-31) — Depreciation Amortization Depletion: 5497000.00
MLAB cash_flow (quarterly, 2024-12-31) — Depreciation And Amortization: 5497000.00
MLAB income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 5429000.00
MLAB income_statement (quarterly, 2024-12-31) — Diluted EPS: -0.31
MLAB income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: -1676000.00
MLAB income_statement (quarterly, 2024-12-31) — EBIT: 625000.00
MLAB income_statement (quarterly, 2024-12-31) — EBITDA: 6122000.00
MLAB cash_flow (quarterly, 2024-12-31) — Effect Of Exchange Rate Changes: -410000.00
MLAB cash_flow (quarterly, 2024-12-31) — End Cash Position: 30956000.00
MLAB cash_flow (quarterly, 2024-12-31) — Financing Cash Flow: -10287000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Finished Goods: 11138000.00
MLAB cash_flow (quarterly, 2024-12-31) — Free Cash Flow: 17316000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -16622000.00
MLAB income_statement (quarterly, 2024-12-31) — General And Administrative Expense: 18472000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Goodwill: 177152000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Goodwill And Other Intangible Assets: 275333000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 39707000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Gross PPE: 57638000.00
MLAB income_statement (quarterly, 2024-12-31) — Gross Profit: 39754000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Income Tax Payable: 1364000.00
MLAB income_statement (quarterly, 2024-12-31) — Interest Expense: 2842000.00
MLAB income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 2842000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Inventory: 28122000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Invested Capital: 350930000.00
MLAB cash_flow (quarterly, 2024-12-31) — Investing Cash Flow: -813000.00
MLAB cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 0.00
MLAB balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 12361000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 94803000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 107164000.00
MLAB cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: 0.00
MLAB cash_flow (quarterly, 2024-12-31) — Long Term Debt Payments: -9438000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Net Debt: 164760000.00
MLAB income_statement (quarterly, 2024-12-31) — Net Income: -1676000.00
MLAB income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: -1676000.00
MLAB income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: -1676000.00
MLAB income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -1676000.00
MLAB income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -1676000.00
MLAB cash_flow (quarterly, 2024-12-31) — Net Income From Continuing Operations: -1676000.00
MLAB income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: -1676000.00
MLAB income_statement (quarterly, 2024-12-31) — Net Interest Income: -2842000.00
MLAB cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: -9438000.00
MLAB cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: -9438000.00
MLAB income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -2842000.00
MLAB cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: 20000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Net PPE: 31602000.00
MLAB cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: -813000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: -120119000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Assets: 1242000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Liabilities: 18800000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Assets: 1242000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Liabilities: 18800000.00
MLAB income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 6122000.00
MLAB income_statement (quarterly, 2024-12-31) — Normalized Income: -1676000.00
MLAB cash_flow (quarterly, 2024-12-31) — Operating Cash Flow: 18129000.00
MLAB cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: 5375000.00
MLAB income_statement (quarterly, 2024-12-31) — Operating Income: 5779000.00
MLAB income_statement (quarterly, 2024-12-31) — Operating Revenue: 62840000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 5433603.00
MLAB balance_sheet (quarterly, 2024-12-31) — Other Current Assets: 2849000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Other Current Borrowings: 100913000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Other Equity Adjustments: -16622000.00
MLAB income_statement (quarterly, 2024-12-31) — Other Gand A: 18472000.00
MLAB income_statement (quarterly, 2024-12-31) — Other Income Expense: -5154000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 98181000.00
MLAB cash_flow (quarterly, 2024-12-31) — Other Non Cash Items: 2131000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Other Non Current Assets: 18126000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Other Non Current Liabilities: 92000.00
MLAB income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: -5154000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Other Payable: 11965000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Payables: 24875000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Payables And Accrued Expenses: 36822000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 10271000.00
MLAB income_statement (quarterly, 2024-12-31) — Pretax Income: -2217000.00
MLAB cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: -813000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Raw Materials: 16584000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Receivables: 38647000.00
MLAB income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 23086000.00
MLAB income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 5497000.00
MLAB cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: -9438000.00
MLAB income_statement (quarterly, 2024-12-31) — Research And Development: 5053000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -180952000.00
MLAB income_statement (quarterly, 2024-12-31) — Selling And Marketing Expense: 10450000.00
MLAB income_statement (quarterly, 2024-12-31) — Selling General And Administration: 28922000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Share Issued: 5433603.00
MLAB income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
MLAB cash_flow (quarterly, 2024-12-31) — Stock Based Compensation: 3239000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 155214000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: -120119000.00
MLAB income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
MLAB income_statement (quarterly, 2024-12-31) — Tax Provision: -541000.00
MLAB income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.24
MLAB balance_sheet (quarterly, 2024-12-31) — Total Assets: 437148000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 250017000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Total Debt: 211612000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 155214000.00
MLAB income_statement (quarterly, 2024-12-31) — Total Expenses: 57061000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 281934000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 326303000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 126056000.00
MLAB income_statement (quarterly, 2024-12-31) — Total Operating Income As Reported: 5779000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 8823000.00
MLAB income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
MLAB income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
MLAB balance_sheet (quarterly, 2024-12-31) — Work In Process: 400000.00
MLAB balance_sheet (quarterly, 2024-12-31) — Working Capital: -45033000.00
MLAB income_statement (annual, 2025-03-31) — +Operating Expense: 134534000.00
MLAB income_statement (quarterly, 2025-03-31) — +Operating Expense: 36943000.00
MLAB income_statement (annual, 2025-03-31) — +Total Revenue: 240978000.00
MLAB income_statement (quarterly, 2025-03-31) — +Total Revenue: 62135000.00
MLAB balance_sheet (annual, 2025-03-31) — Accounts Payable: 5747000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 5747000.00
MLAB balance_sheet (annual, 2025-03-31) — Accounts Receivable: 41970000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 41970000.00
MLAB balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -26421000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -26421000.00
MLAB balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -1186000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -1186000.00
MLAB cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 19145000.00
MLAB cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 6143000.00
MLAB cash_flow (annual, 2025-03-31) — Amortization Of Intangibles: 19145000.00
MLAB cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 6143000.00
MLAB cash_flow (annual, 2025-03-31) — Asset Impairment Charge: 0.00
MLAB income_statement (annual, 2025-03-31) — Basic Average Shares: 5421000.00
MLAB income_statement (quarterly, 2025-03-31) — Basic Average Shares: 5439000.00
MLAB income_statement (annual, 2025-03-31) — Basic EPS: -0.36
MLAB income_statement (quarterly, 2025-03-31) — Basic EPS: -1.31
MLAB cash_flow (annual, 2025-03-31) — Beginning Cash Position: 28214000.00
MLAB cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 30956000.00
MLAB balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 23280000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 23280000.00
MLAB cash_flow (annual, 2025-03-31) — Capital Expenditure: -4499000.00
MLAB cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -1007000.00
MLAB balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 3523000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 3523000.00
MLAB balance_sheet (annual, 2025-03-31) — Capital Stock: 358541000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Capital Stock: 358541000.00
MLAB balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 27321000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 27321000.00
MLAB balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 27321000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 27321000.00
MLAB cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -3468000.00
MLAB cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -870000.00
MLAB cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Financing Activities: -44509000.00
MLAB cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -16193000.00
MLAB cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Investing Activities: -4499000.00
MLAB cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -1007000.00
MLAB cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Operating Activities: 46808000.00
MLAB cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 12665000.00
MLAB cash_flow (annual, 2025-03-31) — Change In Account Payable: -388000.00
MLAB cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 1531000.00
MLAB cash_flow (annual, 2025-03-31) — Change In Accrued Expense: 9504000.00
MLAB cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: 7625000.00
MLAB cash_flow (annual, 2025-03-31) — Change In Inventory: 1153000.00
MLAB cash_flow (quarterly, 2025-03-31) — Change In Inventory: 1692000.00
MLAB cash_flow (annual, 2025-03-31) — Change In Other Working Capital: -938000.00
MLAB cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -89000.00
MLAB cash_flow (annual, 2025-03-31) — Change In Payable: -388000.00
MLAB cash_flow (quarterly, 2025-03-31) — Change In Payable: 1531000.00
MLAB cash_flow (annual, 2025-03-31) — Change In Payables And Accrued Expense: 9116000.00
MLAB cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 9156000.00
MLAB cash_flow (annual, 2025-03-31) — Change In Prepaid Assets: 498000.00
MLAB cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 1943000.00
MLAB cash_flow (annual, 2025-03-31) — Change In Receivables: -2925000.00
MLAB cash_flow (quarterly, 2025-03-31) — Change In Receivables: -3016000.00
MLAB cash_flow (annual, 2025-03-31) — Change In Working Capital: 6904000.00
MLAB cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 9686000.00
MLAB cash_flow (annual, 2025-03-31) — Changes In Account Receivables: -2925000.00
MLAB cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -3016000.00
MLAB cash_flow (annual, 2025-03-31) — Changes In Cash: -2200000.00
MLAB cash_flow (quarterly, 2025-03-31) — Changes In Cash: -4535000.00
MLAB balance_sheet (annual, 2025-03-31) — Common Stock: 358541000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Common Stock: 358541000.00
MLAB cash_flow (annual, 2025-03-31) — Common Stock Dividend Paid: -3468000.00
MLAB cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -870000.00
MLAB balance_sheet (annual, 2025-03-31) — Common Stock Equity: 159830000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 159830000.00
MLAB balance_sheet (annual, 2025-03-31) — Construction In Progress: 1610000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 1610000.00
MLAB income_statement (annual, 2025-03-31) — Cost Of Revenue: 90108000.00
MLAB income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 23723000.00
MLAB balance_sheet (annual, 2025-03-31) — Current Accrued Expenses: 12925000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 12925000.00
MLAB balance_sheet (annual, 2025-03-31) — Current Assets: 102685000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Current Assets: 102685000.00
MLAB balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 3523000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 3523000.00
MLAB balance_sheet (annual, 2025-03-31) — Current Debt: 101047000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Current Debt: 101047000.00
MLAB balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 104570000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 104570000.00
MLAB balance_sheet (annual, 2025-03-31) — Current Deferred Liabilities: 14710000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 14710000.00
MLAB balance_sheet (annual, 2025-03-31) — Current Deferred Revenue: 14710000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 14710000.00
MLAB balance_sheet (annual, 2025-03-31) — Current Liabilities: 163963000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 163963000.00
MLAB cash_flow (annual, 2025-03-31) — Deferred Income Tax: -72000.00
MLAB cash_flow (annual, 2025-03-31) — Deferred Tax: -72000.00
MLAB cash_flow (annual, 2025-03-31) — Depreciation: 5382000.00
MLAB cash_flow (quarterly, 2025-03-31) — Depreciation: 1354000.00
MLAB cash_flow (annual, 2025-03-31) — Depreciation Amortization Depletion: 24527000.00
MLAB cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 7497000.00
MLAB cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 24527000.00
MLAB cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 7497000.00
MLAB income_statement (annual, 2025-03-31) — Diluted Average Shares: 5421000.00
MLAB income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 5439000.00
MLAB income_statement (annual, 2025-03-31) — Diluted EPS: -0.36
MLAB income_statement (quarterly, 2025-03-31) — Diluted EPS: -1.31
MLAB income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: -1974000.00
MLAB income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -7114000.00
MLAB income_statement (annual, 2025-03-31) — EBIT: 17820000.00
MLAB income_statement (quarterly, 2025-03-31) — EBIT: 2980000.00
MLAB income_statement (annual, 2025-03-31) — EBITDA: 42347000.00
MLAB income_statement (quarterly, 2025-03-31) — EBITDA: 10477000.00
MLAB cash_flow (annual, 2025-03-31) — Effect Of Exchange Rate Changes: 1307000.00
MLAB cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 900000.00
MLAB cash_flow (annual, 2025-03-31) — End Cash Position: 27321000.00
MLAB cash_flow (quarterly, 2025-03-31) — End Cash Position: 27321000.00
MLAB cash_flow (annual, 2025-03-31) — Financing Cash Flow: -44509000.00
MLAB cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -16193000.00
MLAB balance_sheet (annual, 2025-03-31) — Finished Goods: 10030000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Finished Goods: 10030000.00
MLAB cash_flow (annual, 2025-03-31) — Free Cash Flow: 42309000.00
MLAB cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 11658000.00
MLAB balance_sheet (annual, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -9775000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -9775000.00
MLAB income_statement (annual, 2025-03-31) — General And Administrative Expense: 73333000.00
MLAB income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 20579000.00
MLAB balance_sheet (annual, 2025-03-31) — Goodwill: 181760000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Goodwill: 181760000.00
MLAB balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 278635000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 278635000.00
MLAB balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 43156000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 43156000.00
MLAB balance_sheet (annual, 2025-03-31) — Gross PPE: 58754000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Gross PPE: 58754000.00
MLAB income_statement (annual, 2025-03-31) — Gross Profit: 150870000.00
MLAB income_statement (quarterly, 2025-03-31) — Gross Profit: 38412000.00
MLAB income_statement (annual, 2025-03-31) — Impairment Of Capital Assets: 0.00
MLAB cash_flow (annual, 2025-03-31) — Income Tax Paid Supplemental Data: 5731000.00
MLAB balance_sheet (annual, 2025-03-31) — Income Tax Payable: 2157000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 2157000.00
MLAB income_statement (annual, 2025-03-31) — Interest Expense: 11859000.00
MLAB income_statement (quarterly, 2025-03-31) — Interest Expense: 2519000.00
MLAB income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 11859000.00
MLAB income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 2519000.00
MLAB cash_flow (annual, 2025-03-31) — Interest Paid Supplemental Data: 11077000.00
MLAB balance_sheet (annual, 2025-03-31) — Inventory: 25365000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Inventory: 25365000.00
MLAB balance_sheet (annual, 2025-03-31) — Invested Capital: 337779000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Invested Capital: 337779000.00
MLAB cash_flow (annual, 2025-03-31) — Investing Cash Flow: -4499000.00
MLAB cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -1007000.00
MLAB cash_flow (annual, 2025-03-31) — Issuance Of Debt: 73465000.00
MLAB cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 0.00
MLAB balance_sheet (annual, 2025-03-31) — Land And Improvements: 889000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 889000.00
MLAB balance_sheet (annual, 2025-03-31) — Long Term Debt: 76902000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 76902000.00
MLAB balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 76902000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 76902000.00
MLAB cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 73465000.00
MLAB cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 0.00
MLAB cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -115811000.00
MLAB cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -17938000.00
MLAB balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 3093000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 3093000.00
MLAB cash_flow (annual, 2025-03-31) — Net Business Purchase And Sale: 0.00
MLAB cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: 0.00
MLAB balance_sheet (annual, 2025-03-31) — Net Debt: 150628000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Net Debt: 150628000.00
MLAB income_statement (annual, 2025-03-31) — Net Income: -1974000.00
MLAB income_statement (quarterly, 2025-03-31) — Net Income: -7114000.00
MLAB income_statement (annual, 2025-03-31) — Net Income Common Stockholders: -1974000.00
MLAB income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -7114000.00
MLAB income_statement (annual, 2025-03-31) — Net Income Continuous Operations: -1974000.00
MLAB income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -7114000.00
MLAB income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -1974000.00
MLAB income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -7114000.00
MLAB income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -1974000.00
MLAB income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -7114000.00
MLAB cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: -1974000.00
MLAB cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -7114000.00
MLAB income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: -1974000.00
MLAB income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -7114000.00
MLAB cash_flow (annual, 2025-03-31) — Net Intangibles Purchase And Sale: -250000.00
MLAB income_statement (annual, 2025-03-31) — Net Interest Income: -11859000.00
MLAB income_statement (quarterly, 2025-03-31) — Net Interest Income: -2519000.00
MLAB cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: -42346000.00
MLAB cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -17938000.00
MLAB cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: -42346000.00
MLAB cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -17938000.00
MLAB income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -11859000.00
MLAB income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -2519000.00
MLAB cash_flow (annual, 2025-03-31) — Net Other Financing Charges: -1339000.00
MLAB cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -29000.00
MLAB balance_sheet (annual, 2025-03-31) — Net PPE: 32333000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Net PPE: 32333000.00
MLAB cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -4249000.00
MLAB cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -757000.00
MLAB balance_sheet (annual, 2025-03-31) — Net Tangible Assets: -118805000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -118805000.00
MLAB balance_sheet (annual, 2025-03-31) — Non Current Deferred Assets: 1371000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 1371000.00
MLAB balance_sheet (annual, 2025-03-31) — Non Current Deferred Liabilities: 20181000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 20181000.00
MLAB balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 1371000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 1371000.00
MLAB balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 20181000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 20181000.00
MLAB income_statement (annual, 2025-03-31) — Normalized EBITDA: 39460000.00
MLAB income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 10477000.00
MLAB income_statement (annual, 2025-03-31) — Normalized Income: -4254730.00
MLAB income_statement (quarterly, 2025-03-31) — Normalized Income: -7114000.00
MLAB cash_flow (annual, 2025-03-31) — Operating Cash Flow: 46808000.00
MLAB cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 12665000.00
MLAB cash_flow (annual, 2025-03-31) — Operating Gains Losses: -2887000.00
MLAB cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -2492000.00
MLAB income_statement (annual, 2025-03-31) — Operating Income: 16336000.00
MLAB income_statement (quarterly, 2025-03-31) — Operating Income: 1469000.00
MLAB income_statement (annual, 2025-03-31) — Operating Revenue: 240978000.00
MLAB income_statement (quarterly, 2025-03-31) — Operating Revenue: 62135000.00
MLAB balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 5455421.00
MLAB balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 5455421.00
MLAB balance_sheet (annual, 2025-03-31) — Other Current Assets: 2873000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 2873000.00
MLAB balance_sheet (annual, 2025-03-31) — Other Current Borrowings: 101047000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 101047000.00
MLAB balance_sheet (annual, 2025-03-31) — Other Equity Adjustments: -9775000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -9775000.00
MLAB income_statement (annual, 2025-03-31) — Other Gand A: 73333000.00
MLAB income_statement (quarterly, 2025-03-31) — Other Gand A: 20579000.00
MLAB income_statement (annual, 2025-03-31) — Other Income Expense: 1484000.00
MLAB income_statement (quarterly, 2025-03-31) — Other Income Expense: 1511000.00
MLAB balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 96875000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 96875000.00
MLAB cash_flow (annual, 2025-03-31) — Other Non Cash Items: 7168000.00
MLAB cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 2022000.00
MLAB balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 18324000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 18324000.00
MLAB balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: 12472000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 12472000.00
MLAB income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: -1403000.00
MLAB income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 1511000.00
MLAB balance_sheet (annual, 2025-03-31) — Other Payable: 15383000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Other Payable: 15383000.00
MLAB balance_sheet (annual, 2025-03-31) — Other Properties: 29882000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Other Properties: 29882000.00
MLAB income_statement (annual, 2025-03-31) — Other Special Charges: -2887000.00
MLAB income_statement (quarterly, 2025-03-31) — Other Special Charges: 0.00
MLAB balance_sheet (annual, 2025-03-31) — Payables: 31758000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Payables: 31758000.00
MLAB balance_sheet (annual, 2025-03-31) — Payables And Accrued Expenses: 44683000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 44683000.00
MLAB balance_sheet (annual, 2025-03-31) — Prepaid Assets: 5156000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 5156000.00
MLAB income_statement (annual, 2025-03-31) — Pretax Income: 5961000.00
MLAB income_statement (quarterly, 2025-03-31) — Pretax Income: 461000.00
MLAB cash_flow (annual, 2025-03-31) — Proceeds From Stock Option Exercised: 2644000.00
MLAB balance_sheet (annual, 2025-03-31) — Properties: 0.00
MLAB balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
MLAB cash_flow (annual, 2025-03-31) — Purchase Of Business: 0.00
MLAB cash_flow (quarterly, 2025-03-31) — Purchase Of Business: 0.00
MLAB cash_flow (annual, 2025-03-31) — Purchase Of Intangibles: -250000.00
MLAB cash_flow (annual, 2025-03-31) — Purchase Of PPE: -4249000.00
MLAB cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -757000.00
MLAB balance_sheet (annual, 2025-03-31) — Raw Materials: 14775000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Raw Materials: 14775000.00
MLAB balance_sheet (annual, 2025-03-31) — Receivables: 41970000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Receivables: 41970000.00
MLAB income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 90108000.00
MLAB income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 23723000.00
MLAB income_statement (annual, 2025-03-31) — Reconciled Depreciation: 24527000.00
MLAB income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 7497000.00
MLAB cash_flow (annual, 2025-03-31) — Repayment Of Debt: -115811000.00
MLAB cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -17938000.00
MLAB income_statement (annual, 2025-03-31) — Research And Development: 19518000.00
MLAB income_statement (quarterly, 2025-03-31) — Research And Development: 5096000.00
MLAB balance_sheet (annual, 2025-03-31) — Retained Earnings: -188936000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -188936000.00
MLAB income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 41683000.00
MLAB income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 11268000.00
MLAB income_statement (annual, 2025-03-31) — Selling General And Administration: 115016000.00
MLAB income_statement (quarterly, 2025-03-31) — Selling General And Administration: 31847000.00
MLAB balance_sheet (annual, 2025-03-31) — Share Issued: 5455421.00
MLAB balance_sheet (quarterly, 2025-03-31) — Share Issued: 5455421.00
MLAB income_statement (annual, 2025-03-31) — Special Income Charges: 2887000.00
MLAB income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
MLAB cash_flow (annual, 2025-03-31) — Stock Based Compensation: 13142000.00
MLAB cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 3138000.00
MLAB balance_sheet (annual, 2025-03-31) — Stockholders Equity: 159830000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 159830000.00
MLAB balance_sheet (annual, 2025-03-31) — Tangible Book Value: -118805000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -118805000.00
MLAB income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 606270.00
MLAB income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
MLAB income_statement (annual, 2025-03-31) — Tax Provision: 7935000.00
MLAB income_statement (quarterly, 2025-03-31) — Tax Provision: 7575000.00
MLAB income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.21
MLAB income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
MLAB balance_sheet (annual, 2025-03-31) — Total Assets: 433348000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Total Assets: 433348000.00
MLAB balance_sheet (annual, 2025-03-31) — Total Capitalization: 236732000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 236732000.00
MLAB balance_sheet (annual, 2025-03-31) — Total Debt: 181472000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Total Debt: 181472000.00
MLAB balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 159830000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 159830000.00
MLAB income_statement (annual, 2025-03-31) — Total Expenses: 224642000.00
MLAB income_statement (quarterly, 2025-03-31) — Total Expenses: 60666000.00
MLAB balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 273518000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 273518000.00
MLAB balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 330663000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 330663000.00
MLAB balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 109555000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 109555000.00
MLAB income_statement (annual, 2025-03-31) — Total Operating Income As Reported: 16336000.00
MLAB income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 1469000.00
MLAB balance_sheet (annual, 2025-03-31) — Total Tax Payable: 10628000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 10628000.00
MLAB income_statement (annual, 2025-03-31) — Total Unusual Items: 2887000.00
MLAB income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
MLAB income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 2887000.00
MLAB income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
MLAB balance_sheet (annual, 2025-03-31) — Work In Process: 560000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Work In Process: 560000.00
MLAB balance_sheet (annual, 2025-03-31) — Working Capital: -61278000.00
MLAB balance_sheet (quarterly, 2025-03-31) — Working Capital: -61278000.00
MLAB income_statement (quarterly, 2025-06-30) — +Operating Expense: 33875000.00
MLAB income_statement (quarterly, 2025-06-30) — +Total Revenue: 59543000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 6270000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 39068000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -27827000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -1190000.00
MLAB cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 4553000.00
MLAB cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 4553000.00
MLAB income_statement (quarterly, 2025-06-30) — Basic Average Shares: 5465000.00
MLAB income_statement (quarterly, 2025-06-30) — Basic EPS: 0.87
MLAB cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 27321000.00
MLAB cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -1009000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 16409000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Capital Stock: 361361000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 21279000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 21279000.00
MLAB cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -873000.00
MLAB cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -8427000.00
MLAB cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -1009000.00
MLAB cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 1893000.00
MLAB cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 212000.00
MLAB cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: -5928000.00
MLAB cash_flow (quarterly, 2025-06-30) — Change In Inventory: -3290000.00
MLAB cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 55000.00
MLAB cash_flow (quarterly, 2025-06-30) — Change In Payable: 212000.00
MLAB cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -5716000.00
MLAB cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -2436000.00
MLAB cash_flow (quarterly, 2025-06-30) — Change In Receivables: 3436000.00
MLAB cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -7951000.00
MLAB cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 3436000.00
MLAB cash_flow (quarterly, 2025-06-30) — Changes In Cash: -7543000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Common Stock: 361361000.00
MLAB cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -873000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 172496000.00
MLAB income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 22604000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 3860000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Current Assets: 98258000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 3752000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Current Debt: 101651000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 105403000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 15077000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 15077000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 149494000.00
MLAB cash_flow (quarterly, 2025-06-30) — Depreciation: 1404000.00
MLAB cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 5957000.00
MLAB cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 5957000.00
MLAB income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 5553000.00
MLAB income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.85
MLAB income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 4742000.00
MLAB income_statement (quarterly, 2025-06-30) — EBIT: 9210000.00
MLAB income_statement (quarterly, 2025-06-30) — EBITDA: 15167000.00
MLAB cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 1501000.00
MLAB cash_flow (quarterly, 2025-06-30) — End Cash Position: 21279000.00
MLAB cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -8427000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Finished Goods: 11391000.00
MLAB cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 884000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -3798000.00
MLAB income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 17958000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Goodwill: 188050000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 285451000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 40258000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Gross PPE: 59519000.00
MLAB income_statement (quarterly, 2025-06-30) — Gross Profit: 36939000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 2419000.00
MLAB income_statement (quarterly, 2025-06-30) — Interest Expense: 2198000.00
MLAB income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 2198000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Inventory: 28106000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Invested Capital: 353680000.00
MLAB cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -1009000.00
MLAB cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 10500000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 12657000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 79533000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 92190000.00
MLAB cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 10500000.00
MLAB cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -7438000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Net Debt: 159905000.00
MLAB cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: -5986000.00
MLAB income_statement (quarterly, 2025-06-30) — Net Income: 4742000.00
MLAB income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 4742000.00
MLAB income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 4742000.00
MLAB income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 4742000.00
MLAB income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 4742000.00
MLAB cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 4742000.00
MLAB income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 4742000.00
MLAB income_statement (quarterly, 2025-06-30) — Net Interest Income: -2198000.00
MLAB cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 3062000.00
MLAB cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 3062000.00
MLAB income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -2198000.00
MLAB cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -10616000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Net PPE: 31692000.00
MLAB cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -1009000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -112955000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 1474000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 21563000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 1474000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 21563000.00
MLAB income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 15167000.00
MLAB income_statement (quarterly, 2025-06-30) — Normalized Income: 4742000.00
MLAB cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 1893000.00
MLAB cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -5986000.00
MLAB income_statement (quarterly, 2025-06-30) — Operating Income: 3064000.00
MLAB income_statement (quarterly, 2025-06-30) — Operating Revenue: 59543000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 5501454.00
MLAB balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 3306000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 101651000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -3798000.00
MLAB income_statement (quarterly, 2025-06-30) — Other Gand A: 17958000.00
MLAB income_statement (quarterly, 2025-06-30) — Other Income Expense: 6146000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 97401000.00
MLAB cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 1250000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 18868000.00
MLAB income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 6146000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Other Payable: 7149000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Payables: 25154000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 29014000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 6499000.00
MLAB income_statement (quarterly, 2025-06-30) — Pretax Income: 7012000.00
MLAB cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -1009000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Raw Materials: 16089000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Receivables: 39068000.00
MLAB income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 22604000.00
MLAB income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 5957000.00
MLAB cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -7438000.00
MLAB income_statement (quarterly, 2025-06-30) — Research And Development: 4984000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -185067000.00
MLAB income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 10933000.00
MLAB income_statement (quarterly, 2025-06-30) — Selling General And Administration: 28891000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Share Issued: 5501454.00
MLAB income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
MLAB cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 3881000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 172496000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -112955000.00
MLAB income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
MLAB income_statement (quarterly, 2025-06-30) — Tax Provision: 2270000.00
MLAB income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.32
MLAB balance_sheet (quarterly, 2025-06-30) — Total Assets: 435743000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 252029000.00
MLAB balance_sheet (quarterly, 2025-06-30) — Total Debt: 197593000.00